Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 30673

1.

Ezetimibe plus simvastatin for the treatment of hypercholesterolemia.

Gryn SE, Hegele RA.

Expert Opin Pharmacother. 2015 Apr 28:1-8. [Epub ahead of print]

PMID:
25920750
2.

Continuation of Statin Therapy and Vasopressor Use in Septic Shock.

Zechmeister C, Hurren J, McNorton K.

Ann Pharmacother. 2015 Apr 20. pii: 1060028015579987. [Epub ahead of print]

PMID:
25896127
3.

Is lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case-control study.

Ashrani AA, Barsoum MK, Crusan DJ, Petterson TM, Bailey KR, Heit JA.

Thromb Res. 2015 Apr 11. pii: S0049-3848(15)00160-7. doi: 10.1016/j.thromres.2015.04.005. [Epub ahead of print]

PMID:
25891841
4.

[Overexpression of LaeA enhances mevastatin production and reduces sporulation of Penicillium citrinum].

Zheng Y, Cao S, Huang Y, Liao G, Hu C.

Wei Sheng Wu Xue Bao. 2014 Dec 4;54(12):1438-45. Chinese.

PMID:
25876329
5.

[The alternative view on diagnostic of hyperlipoproteinemia, cholesterol lipoproteins of low density and effect of statins: a lecture].

Tupoleva TA, Tikhomirov DS, Grumbkova LO, Ignatova EN, Romanova TIu, Filatov FP, Garanzha TA.

Klin Lab Diagn. 2015 Jan;60(1):27-38. Russian.

PMID:
25874302
6.

Sex, Prescribing Practices and Guideline Recommended, Blood Pressure, and LDL Cholesterol Targets at Baseline in the BARI 2D Trial.

Magee MF, Tamis-Holland JE, Lu J, Bittner VA, Brooks MM, Lopes N, Jacobs AK, Study Group B2.

Int J Endocrinol. 2015;2015:610239. Epub 2015 Mar 19.

7.

[2014 literature findings in internal general medicine].

Vu F, Guinand S, Pasche O, Zürcher S, Ronga A, Arnold C, Barras D, Chiarini B, Bodenmann P.

Rev Med Suisse. 2015 Jan 21;11(458):174, 176-80. French.

PMID:
25831609
8.

[2014 update in general internal medicine].

Brander P, Amstutz S, Della Santa P, Favrod-Coune T, François A, Keta A, Pasche S, Wuillemin T, Gaspoz JM.

Rev Med Suisse. 2015 Jan 21;11(458):170-3. French.

PMID:
25831608
9.

A victory for statins or a defeat for diet policies? Cholesterol falls in Poland in the past decade: A modeling study.

Bandosz P, O'Flaherty M, Rutkowski M, Kypridemos C, Guzman-Castillo M, Gillespie DO, Solnica B, Pencina MJ, Wyrzykowski B, Capewell S, Zdrojewski T.

Int J Cardiol. 2015 Apr 15;185:313-9. doi: 10.1016/j.ijcard.2015.03.079. Epub 2015 Mar 10.

PMID:
25828672
10.

Effect of pretreatment of ezetimibe/simvastatin on arterial healing and endothelialization after drug-eluting stent implantation in a porcine coronary restenosis model.

Sim DS, Jeong MH, Park DS, Kim JH, Lim KS, Kim HK, Kim SS, Cho JY, Jeong HC, Park KH, Hong YJ, Kim JH, Ahn Y, Cho JG, Park JC.

Korean Circ J. 2015 Mar;45(2):110-6. doi: 10.4070/kcj.2015.45.2.110. Epub 2015 Mar 24.

11.

[Two catheters for one coronary perforation].

Barbieri L, Verdoia M, Schaffer A, Marino P, De Luca G.

G Ital Cardiol (Rome). 2015 Feb;16(2):112-5. doi: 10.1714/1798.19588. Italian.

PMID:
25805096
12.

Statin Treatment in Multiple Sclerosis: A Systematic Review and Meta-Analysis.

Pihl-Jensen G, Tsakiri A, Frederiksen JL.

CNS Drugs. 2015 Mar 21. [Epub ahead of print]

PMID:
25795002
13.

Response: “Actually, it’s more of a guideline than a rule”.

Halperin JL.

J Am Coll Cardiol. 2015 Feb 3;65(4):400. No abstract available.

PMID:
25793247
14.

Lowering LDL cholesterol is good, but how and in whom?

Stone NJ, Lloyd-Jones DM.

N Engl J Med. 2015 Apr 16;372(16):1564-5. doi: 10.1056/NEJMe1502192. Epub 2015 Mar 15. No abstract available.

PMID:
25773740
15.

Efficacy and safety of evolocumab in reducing lipids and cardiovascular events.

Sabatine MS, Giugliano RP, Wiviott SD, Raal FJ, Blom DJ, Robinson J, Ballantyne CM, Somaratne R, Legg J, Wasserman SM, Scott R, Koren MJ, Stein EA; Open-Label Study of Long-Term Evaluation against LDL Cholesterol (OSLER) Investigators.

N Engl J Med. 2015 Apr 16;372(16):1500-9. doi: 10.1056/NEJMoa1500858. Epub 2015 Mar 15.

PMID:
25773607
16.

Efficacy and safety of alirocumab in reducing lipids and cardiovascular events.

Robinson JG, Farnier M, Krempf M, Bergeron J, Luc G, Averna M, Stroes ES, Langslet G, Raal FJ, El Shahawy M, Koren MJ, Lepor NE, Lorenzato C, Pordy R, Chaudhari U, Kastelein JJ; ODYSSEY LONG TERM Investigators.

N Engl J Med. 2015 Apr 16;372(16):1489-99. doi: 10.1056/NEJMoa1501031. Epub 2015 Mar 15.

PMID:
25773378
17.

Statin intolerance: reconciling clinical trials and clinical experience.

Newman CB, Tobert JA.

JAMA. 2015 Mar 10;313(10):1011-2. doi: 10.1001/jama.2015.1335. No abstract available.

PMID:
25756433
18.

Deciphering cholesterol treatment guidelines: a clinician's perspective.

Ganda OP.

JAMA. 2015 Mar 10;313(10):1009-10. doi: 10.1001/jama.2015.216. No abstract available.

PMID:
25756432
19.

A proposal to incorporate trial data into a hybrid ACC/AHA algorithm for the allocation of statin therapy in primary prevention.

Ridker PM, Rose L, Cook NR.

J Am Coll Cardiol. 2015 Mar 10;65(9):942-8. doi: 10.1016/j.jacc.2014.12.028. Review.

PMID:
25744012
20.

[Lipid lowering by rosuvastatin: how do statins differ?].

Laufs U.

Dtsch Med Wochenschr. 2015 Mar;140(5):313. doi: 10.1055/s-0041-100713. Epub 2015 Mar 3. Review. German. No abstract available.

PMID:
25734669
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk